Moreover, the referred papers highlight the role of EP300 and p53 in controlling the cellular level of protein transporters functionally associated with an active drug efflux, thus their potential involvement in the development of cisplatin resistance in cancer cells. The gene discussed is TP53; the disease is cancer.